Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Elisabet Bascuñana"'
Autor:
Verónica Saludes, Elisabet Bascuñana, Elena Jordana-Lluch, Sònia Casanovas, Mercè Ardèvol, Esther Soler, Ramón Planas, Vicente Ausina, Elisa Martró
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e72600 (2013)
BACKGROUND:Only about 50% of patients chronically infected with HCV genotype 1 (HCV-1) respond to treatment with pegylated interferon-alfa and ribavirin (dual therapy), and protease inhibitors have to be administered together with these drugs increas
Externí odkaz:
https://doaj.org/article/aa3eb4b0235041bfb8ef2e7ac7dc51dc
Autor:
Lurdes Matas, Gema Fernández, Evelin López, Pep Coll, Belén Rivaya, Vicente Ausina, Verónica Saludes, Elisabet Bascuñana, Elisa Martró, Victoria González, Clara Marcó
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 34:471-476
Introduction Sexually transmitted infections (STI) are currently on the increase worldwide. New molecular tools have been developed in the past few years in order to improve their diagnosis. An evaluation was carried out using a new commercially avai
Autor:
Rafael Muñoz, Elisabet Bascuñana, Laura Fernàndez-López, Percy Fernández-Dávila, A. Morales-Carmona, Jordi Casabona, Verónica Saludes, Eva Loureiro, Elisa Martró, Laia Ferrer, M. Jiménez, Cinta Folch
Publikováno v:
Journal of viral hepatitis. 25(3)
Alternative strategies are required to enhance the diagnosis of silent hepatitis C virus (HCV) infections in hard-to-reach key populations at risk. Among them, HCV prevalence and bio-behavioural data is scarce for HIV-negative men who have sex with m
Accuracy of a commercially available assay for HCV genotyping and subtyping in the clinical practice
Autor:
Meissiner Gomes-Fernandes, Elena Jordana-Lluch, Lurdes Matas, Sònia Casanovas, Victoria González, Vicenç Ausina, Elisabet Bascuñana, Verónica Saludes, Elisa Martró
Publikováno v:
Journal of Clinical Virology. 58:593-597
Background Hepatitis C virus (HCV) genotyping is mandatory for tailoring dose and duration of pegylated interferon-α plus ribavirin treatment and for deciding on triple therapy eligibility. Additionally, subtyping may play a role in helping to selec
Autor:
N. García-Sierra, Rosana Díaz, Mariona Llatjós, Antoni Tarrats, Vicente Ausina, Maria Isabel Bonilla Carrasco, Elisa Martró, Guillem Sirera, Lurdes Matas, Eva Castellà, Elisabet Bascuñana
Publikováno v:
Journal of Clinical Microbiology. 47:2165-2169
Cervical cancer is the second-most prevalent cancer in young women around the world. Infection with human papillomavirus (HPV), especially high-risk HPV types (HR-HPV), is necessary for the development of this cancer. HPV-DNA detection is increasingl
Autor:
Juan Ignacio Esteban, Elisabet Bascuñana, Damir Garcia-Cehic, Josep Quer, Josep Gregori, Verónica Saludes, Elisa Martró, Vicente Ausina
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 78
Background Hepatitis C virus (HCV) genotyping is crucial in clinical practise for determining the type and duration of antiviral therapy. Between 2009 and 2014, 24 (7.95%) of all HCV genotype 3 (HCV-3) cases obtained indeterminate results via the Rea
Autor:
A. Morales-Carmona, Laia Ferrer, Elisabet Bascuñana, Jordi Casabona, Cinta Folch, Eva Loureiro, Verónica Saludes, Rafael Muñoz, M. Jiménez, Percy Fernández-Dávila, L. Fernández, Elisa Martró
Publikováno v:
Journal of Clinical Virology. 82:S73-S74
Autor:
B. Reinhardt, M.A. Cuesta, Vicenç Ausina, Elisabet Bascuñana, Lurdes Matas, Elisa Martró, Verónica Saludes, J. Bolaños, M. Jiménez
Publikováno v:
Journal of Clinical Virology. 82:S74-S75
Autor:
Elisabet Bascuñana, Vicente Ausina, Mercè Ardèvol, Ramon Planas, Sònia Casanovas, Elisa Martró, Elena Jordana-Lluch, Esther Soler, Verónica Saludes
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 8, p e72600 (2013)
PLoS ONE, Vol 8, Iss 8, p e72600 (2013)
BACKGROUND:Only about 50% of patients chronically infected with HCV genotype 1 (HCV-1) respond to treatment with pegylated interferon-alfa and ribavirin (dual therapy), and protease inhibitors have to be administered together with these drugs increas
Autor:
Luis Barbero, Elisabet Bascuñana, Dolors Carnicer-Pont, Nuria Lleopart, Jordi Casabona, Rossie Lugo, Evelin López Corbeto, Victoria Humet, Victoria González
Publikováno v:
Sexual health. 9(2)
Objective To determine the prevalence of Chlamydia trachomatis (CT) and high risk factors for acquisition in preventive prisoners in Catalonia. Methods: Cross-sectional study of a convenience sample of 478 prisoners aged between 18 and 35 years was a